Physician

Loganathan Elangovan, MD

According to 2025 Medicare claims, Loganathan Elangovan, MD (NPI: 1477572881) practices nephrology in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Waukesha, WI. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES SC (NPI: 1871679514; TIN: 391717839) and primary practice location at 53186-5974. Elangovan is affiliated with the ProHealth Solutions, LLC (ACO ID: A4979), participating under the MSSP model.

Elangovan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,150 traditional Medicare patients, billed 26,135 HCPCS/CPT codes, and received $573,712 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 6,978 prescription claims across 1,033 beneficiaries totaling $1,126,198 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 156 claims. Open Payments data shows 16 records totaling $794. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $389,913 to $573,712. Similarly, Part D prescription costs have risen steadily, from $629,903 to $1,126,198. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,253	4,580	$389,913
2016	1,367	4,589	$406,832
2017	1,308	4,297	$365,571
2018	1,363	4,589	$357,844
2019	1,364	4,429	$374,773
2020	1,353	6,925	$426,309
2021	1,458	13,944	$567,436
2022	1,334	26,356	$607,190
2023	1,213	33,642	$646,079
2024	1,150	26,135	$573,712

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	694	6,130	$629,903
2016	760	6,333	$658,269
2017	813	6,306	$904,037
2018	867	6,583	$862,552
2019	899	6,394	$795,395
2020	957	6,923	$885,400
2021	1,002	6,897	$767,991
2022	1,015	6,769	$911,998
2023	1,015	6,967	$922,139
2024	1,033	6,978	$1,126,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$269
2017	N/R	68	$2,534
2018	N/R	49	$1,972
2019	N/R	N/R	N/R
2020	N/R	28	$264
2021	N/R	44	$1,080
2022	22	92	$18,401
2023	N/R	82	$5,266
2024	N/R	156	$7,029

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	184	207	$123
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	296	814	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	699	1,118	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	613	836	$12
96372	Injection of drug or substance under skin or into muscle	83	196	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	201	7,538	$137,418
Thiola Ec	Tiopronin	23	690	$131,792
Kerendia	Finerenone	56	2,399	$48,771
Veltassa	Patiromer Calcium Sorbitex	49	1,926	$38,170
Tolvaptan	Tolvaptan	17	401	$37,967

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	13	$2,893
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	33	$2,073
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	21	$769
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	41	$665
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	36	$621

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$794	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Loganathan Elangovan, MD?

Tedicare shows public-source Medicare data for Loganathan Elangovan, MD (NPI 1477572881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Loganathan Elangovan, MD have ACO affiliation data?

Loganathan Elangovan, MD is shown with ACO affiliation data for ProHealth Solutions, LLC (MSSP, ACO ID A4979).

What billing organization is linked to Loganathan Elangovan, MD?

Loganathan Elangovan, MD is linked to NEPHROLOGY ASSOCIATES SC (billing NPI 1871679514) in the available physician profile data.

Does Loganathan Elangovan, MD have Open Payments data?

Loganathan Elangovan, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.